Skip to main content

Table 2 Multivariate analysis (logistic regression and Cox regression analysis)

From: Identification of biology-based breast cancer types with distinct predictive and prognostic features: role of steroid hormone and HER2 receptor expression in patients treated with neoadjuvant anthracycline/taxane-based chemotherapy

  correlation with pCR correlation with survival
  OR 95% CI p hazard ratio 95% CI p
biology-based tumor type    0.258a    < 0.0001a
   HR+/HER2- 1.00    1.00   
   HR+/HER2+ 14.28 1.05-194.31 0.046 1.88 0.39-9.04 0.432
   HR-/HER2+ 5.35 0.25-116.83 0.287 16.78 5.75-48.97 < 0.0001
   HR-/HER2- 6.01 0.53-67.84 0.147 4.24 1.62-11.12 0.003
Ki67       
   <= 20% 1.00      
   > 20% 10.37 1.29-83.28 0.028 - - -
CK5/6       
   negative 1.00      
   positive 0.51 0.04-7.57 0.627 - - -
therapy arm       
   ADoc 1.00      
   ACDoc 11.97 1.17-122.16 0.036 - - -
grade       
   G1-2 1.00      
   G3 5.59 0.93-33.70 0.061 - - -
ypN       
   cN0     1.00   
   cN1-2 - - - 2.77 1.24-6.18 0.013
pCR       
   no pCR     1.00   
   pCR - - - 0.18 0.02-1.43 0.104
  1. OR: odds ratio; CI: confidence interval; a: overall significance.